产品
编 号：F042937
分子式：C24H32O4
分子量：384.51
分子式：C24H32O4
分子量：384.51
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
640
In-stock
10mg
880
In-stock
25mg
1508
In-stock
50mg
2080
In-stock
100mg
2912
In-stock
结构图
CAS No: 113-38-2
产品详情
生物活性：
Estradiol dipropionate is a combined estrogen-progesterone, acts as an estrogen and progesterone agonist.
体内研究：
Treatment of Estradiol dipropionate (2μg per 100 g; single subcutaneous injection) and Chorionic gonadotropin (10 IU per 100 g; sc; twice a day) for 2 days, levels of β-catenin and GSK-3β in luminal and glandular epithelia are lower in Ovariectomized mice.Treatment of Estradiol dipropionate (2 μg per 100 g; once a week) and Chorionic gonadotropin ((10 IU per 100 g; once a day) for a month, the incidence of atypical endometrial hyperplasia is significantly higher, the level of β-catenin is slightly higher, and the expression of GSK-3β is lower in luminal and glandular epithelia.
Estradiol dipropionate is a combined estrogen-progesterone, acts as an estrogen and progesterone agonist.
体内研究：
Treatment of Estradiol dipropionate (2μg per 100 g; single subcutaneous injection) and Chorionic gonadotropin (10 IU per 100 g; sc; twice a day) for 2 days, levels of β-catenin and GSK-3β in luminal and glandular epithelia are lower in Ovariectomized mice.Treatment of Estradiol dipropionate (2 μg per 100 g; once a week) and Chorionic gonadotropin ((10 IU per 100 g; once a day) for a month, the incidence of atypical endometrial hyperplasia is significantly higher, the level of β-catenin is slightly higher, and the expression of GSK-3β is lower in luminal and glandular epithelia.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备